Results 31 to 40 of about 36,107 (253)

Formoterol for the Treatment of Chronic Obstructive Pulmonary Disease

open access: yesInternational Journal of COPD, 2020
Donald P Tashkin Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USACorrespondence: Donald P TashkinDavid Geffen School of Medicine at UCLA, 10388 Le Conte Avenue, Los Angeles, CA 90095, USATel +1 310 825 3163Fax +1 310 ...
Tashkin DP
doaj  

A study of correlation between body mass index and GOLD staging of chronic obstructive pulmonary disease patients

open access: yesThe Journal of Association of Chest Physicians, 2013
Background: The association between low body mass index (BMI) and poor prognosis of patients with chronic obstructive pulmonary disease (COPD) is a common clinical observation and it varies with different stages of COPD. Aims: To find out any correlation
Mrinmoy Mitra   +8 more
doaj   +1 more source

Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity

open access: yesSensors, 2022
The purpose of this study was to explore the relationships between heart rate variability (HRV) and various phenotypic measures that relate to health and functional status in chronic obstructive pulmonary disease (COPD), and secondly, to demonstrate the ...
Seon-Cheol Park   +8 more
doaj   +1 more source

Chest Pain Relieved with a Bronchodilator or Other Asthma Drugs

open access: yesAllergology International, 2009
Background: Although many patients who experience chest pain or pressure consult their physicians, unfortunately a large number of them do not, and consequently they remain undiagnosed and untreated.
Hirokazu Taniguchi   +3 more
doaj   +1 more source

Pharmacological therapy for stable chronic obstructive pulmonary disease

open access: yesChronic Diseases and Translational Medicine, 2023
In recent years, emphasis has shifted from preventing and treating chronic obstructive pulmonary disease (COPD) to early prevention, early treatment, and disease stabilization, with the main goal of improving patients’ quality of life and reducing the ...
Ruirui Duan, Baicun Li, Ting Yang
doaj   +1 more source

The Spasmolytic, Bronchodilator, and Vasodilator Activities of Parmotrema perlatum Are Explained by Anti-Muscarinic and Calcium Antagonistic Mechanisms

open access: yesMolecules, 2021
Parmotremaperlatum is traditionally used in different areas of Pakistan to treat gastrointestinal, respiratory, and vascular diseases. This study evaluates the underlying mechanisms for traditional uses of P.
Musaddique Hussain   +9 more
doaj   +1 more source

How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC

open access: yesEuropean Journal of Heart Failure, EarlyView.
Linking guideline‐directed medical therapy (GDMT) implementation and appropriate polypharmacy management in heart failure (HF). Polypharmacy can represent a barrier to the proper implementation of life‐prolonging GDMT for HF. A reasonable balance between the optimization of GDMT and avoiding inappropriate polypharmacy is mandatory in the contemporary ...
Davide Stolfo   +27 more
wiley   +1 more source

Bronchial Thermoplasty in Asthma

open access: yesAllergology International, 2006
In this review we discuss the potential of a new procedure, termed Bronchial Thermoplasty to prevent serious consequences resulting from excessive airway narrowing.
Wayne Mitzner
doaj   +1 more source

The Development and Challenges of PET/MRI Dual‐Modality Imaging Probes—An Update

open access: yesJournal of Magnetic Resonance Imaging, EarlyView.
ABSTRACT The integration of Positron emission tomography (PET) with Magnetic resonance imaging (MRI) combines the functional imaging capabilities of PET with the high‐resolution anatomical detail of MRI, creating a synergistic platform for advanced diagnostic imaging and image‐guided therapies. Central to the success of this dual‐modality system is the
Maryam Sabbaghan   +5 more
wiley   +1 more source

Assessment of bronchodilator responsiveness to salbutamol or ipratropium using different criteria in treatment-naïve patients with asthma and COPD

open access: yesEuropean Clinical Respiratory Journal
Background The criteria for significant bronchodilator responsiveness (BDR) were published in 2005 by the European Respiratory Society/American Thoracic Society, which were revised in 2021, however, data on the agreement between these two recommendations
Zsófia Lázár   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy